Task: Answer the multiple choice question.
Query: Which drug exhibits a 7.467\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Cc1cccc(/C=C2/Sc3ccc(C(=O)NCCN4CCCC4)cc3NC2=O)c1
[b] CCC(Oc1ccccc1)C(=O)NN1C(=O)NC(C)(CC)C1=O
Answer: b. CCC(Oc1ccccc1)C(=O)NN1C(=O)NC(C)(CC)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(Oc1ccccc1)C(=O)NN1C(=O)NC(C)(CC)C1=O
CCC(Oc1ccccc1)C(=O)NN1C(=O)NC(C)(CC)C1=O
N-(4-ethyl-4-methyl-2,5-dioxoimidazolidin-1-yl)-2-phenoxybutanamide